Has Terrence Keaney, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,119,873 in general payments to Terrence Keaney, MD across 764 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Terrence Keaney, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Terrence Keaney, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Terrence Keaney, MD

Dermatology · Washington, DCNPI 1902049489

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $678,982 of the $1,119,873 with a category attached, or 60.6%. AbbVie accounts for 86.6% of it on its own, with 22 other manufacturers making up the rest. Among dermatology clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,119,873in general payments, 2019–2025

Across 764 payments — averaging $1465.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$970K
Merz North America, Inc.$79K
Lilly USA, LLC$26K
EPI Health, LLC$20K
Dermira, Inc.$9K
Solta Medical, A Division Of Bausch Health US, LLC$8K
plus $9K from 17 others

$2,334,507in research payments, 2019–2025

Across 251 payments — averaging $9300.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$2.3M
Merz North America, Inc.$27K
Sun Pharmaceutical Industries Inc.$4K
Taro Pharmaceuticals USA, Inc.$2K

What the payments were for

Consulting fees$678,98261%
Speaking & faculty fees$331,28530%
Travel & lodging$87,2698%
Food & beverage$22,1092%
Education$2290%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	534	$970,166
Merz North America, Inc.	111	$78,846
Lilly USA, LLC	31	$25,925
EPI Health, LLC	5	$19,584
Dermira, Inc.	9	$8,523
Solta Medical, A Division Of Bausch Health US, LLC	8	$7,818
Aclaris Therapeutics, Inc.	8	$4,608
Sun Pharmaceutical Industries Inc.	5	$3,164
Galderma Laboratories, L.p.	14	$324
Johnson & Johnson	4	$142
Bristol Myers Squibb	7	$109
Endo Pharmaceuticals Inc.	2	$108
Almirall LLC	5	$103
Novartis	4	$80
Incyte Corporation	3	$67
UCB, Inc.	2	$54
Arcutis Biotherapeutics, Inc.	3	$51
Pfizer	2	$47
Sanofi	2	$42
LEO Pharma Inc.	2	$42
Strata Skin Sciences, Inc.	1	$39
Encore Dermatology Inc.	1	$20
Merck	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BOTOX$296,900
BOTOX COSMETIC$64,171
XEOMIN$57,643
OLUMIANT$23,600
Rhofade$21,480
Sitavig$19,500
Cloderm$19,500
Minolira 105mg$19,500
Minolira 135mg$19,500
QBREXZA$8,503
THERMAGE FLX$7,641
Clear & Brilliant$7,641
Winlevi$3,000
ESKATA$2,500
ALLODERM$2,350
ASCLERA$237

How this compares

$1,119,873 in reported general payments places this provider in the 95th percentile of 73 dermatology providers in District of Columbia.

See all dermatology providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$13,060

Medicare patients

Services billed

250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Washington

Jonathan SilverbergWashington$4.5M
Adam FriedmanWashington$2.2M
Candrice HeathWashington$168K
Agnes ChangWashington$109K
Todd PerkinsWashington$102K
Karl SaardiWashington$101K
Noelle SherberWashington$96K
Yolanda HolmesWashington$80K
Cheri FreyWashington$79K
Ginette OkoyeWashington$70K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →